Volitionrx (VNRX) Share-based Compensation (2011 - 2026)
Volitionrx's (VNRX) quarterly Share-based Compensation came in at $1.6 million in Q4 2025, up 1807.77% YoY from $82812.0 in Q4 2024, and up 524.8% on a QoQ basis from -$371906.0 in Q2 2025.
Volitionrx (VNRX) Share-based Compensation (2011 - 2026) Analysis & Trends
Volitionrx (VNRX) has 15 years of Share-based Compensation data on file, last reported at $1.6 million in Q4 2025.
- Quarterly Share-based Compensation rose 1807.77% year-over-year to $1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 million (up 182.15% YoY) and the FY2025 annual result came in at $1.7 million, up 1143.19% from the prior year.
- Share-based Compensation advanced to $1.6 million in Q4 2025, from -$371906.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $3.0 million in Q4 2022 to a low of -$371906.0 in Q2 2025.
- A 5-year average of $607112.9 and a median of $537980.0 in 2023 frame the typical range for Share-based Compensation.
- The widest YoY moves for Share-based Compensation: up 14641.15% in 2025, down 278.76% in 2025.
- Tracing VNRX's Share-based Compensation over 5 years: stood at $276729.0 in 2021, then jumped by 971.22% to $3.0 million in 2022, then plunged by 95.83% to $123647.0 in 2023, then tumbled by 33.03% to $82812.0 in 2024, then jumped by 1807.77% to $1.6 million in 2025.
- The last three Share-based Compensation figures came in at $1.6 million (Q4 2025), -$371906.0 (Q2 2025), and $451374.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Volitionrx | 1.19 Mn | -1.60 Mn | - | 729,043.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 729,043.00 |
| Jun 30, 2026 | 729,043.00 |
| Dec 31, 2025 | 1.58 Mn |
| Dec 31, 2025 | 1.58 Mn |
| Jun 30, 2025 | -371,906.00 |
| Jun 30, 2025 | -371,906.00 |
| Mar 31, 2025 | 451,374.00 |
| Mar 31, 2025 | 451,374.00 |
| Dec 31, 2024 | 82,812.00 |
| Dec 31, 2024 | 82,812.00 |
| Sep 30, 2024 | 323,539.00 |
| Sep 30, 2024 | 323,539.00 |
| Jun 30, 2024 | 208,046.00 |
| Jun 30, 2024 | 208,046.00 |
| Mar 31, 2024 | 3,062.00 |
| Mar 31, 2024 | 3,062.00 |
| Dec 31, 2023 | 123,647.00 |
| Dec 31, 2023 | 123,647.00 |
| Sep 30, 2023 | 537,980.00 |
| Sep 30, 2023 | 537,980.00 |